Designed Extension of Studies Based on Conditional Power

DOI10.2307/2533262zbMath0875.62506OpenAlexW1986502618WikidataQ70971455 ScholiaQ70971455MaRDI QIDQ4335625

Michael A. Proschan, Sally A. Hunsberger

Publication date: 9 November 1997

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2533262

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Parametric hypothesis testing (62F03)

Related Items

Benefit–Risk Evaluation of Multi-Stage Adaptive Designs, The Influence of Biostatistics at the National Heart, Lung, and Blood Institute, Optimal Conditional Error Functions for the Control of Conditional Power, Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials, Novel Bayesian Adaptive Designs and Their Applications in Cancer Clinical Trials, Longitudinal clinical trials with adaptive choice of follow‐up time, An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size, A note on the shape of sample size functions of optimal adaptive two-stage designs, Unnamed Item, Methodology and application of adaptive and sequential approaches in contemporary clinical trials, Optimization of adaptive designs with respect to a performance score, A comparison between two treatments in a clinical trial with an ethical allocation design, Asymptotic properties of maximum likelihood estimators with sample size recalculation, Single-arm phase II three-outcome designs with handling of over-running/under-running, Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials, Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations, Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials, Optimal two-stage group-sequential designs, Interim Design Modifications in Time-to-Event Studies, Probabilistic Foundation of Confirmatory Adaptive Designs, Development of Adaptive Group Sequential Procedure for Changing Sample Size, Robustness of sample size re-estimation with interim binary data for double-blind clinical trials, Modification of Sample Size in Group Sequential Clinical Trials, Adaptive Sample Size Calculations in Group Sequential Trials, Interim Analysis and Sample Size Reassessment, On the efficiency of adaptive designs for flexible interim decisions in clinical trials, On design and inference for two-stage adaptive clinical trials with dependent data, Internal pilots for observational studies, Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs, Sample size reassessment for a two-stage design controlling the false discovery rate, Sequential Methods in Multi-Arm Clinical Trials, p-Value calculation for multi-stage additive tests, Analysis of ``learn-as-you-go (LAGO) studies, Discussion on “Second-Guessing Clinical Trial Designs” by Jonathan J. Shuster and Myron N. Chang, Monitoring Continuous Long-Term Outcomes in Adaptive Designs, On Sample Size and Inference for Two‐Stage Adaptive Designs, Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches, Monitoring Clinical Trials with Multiple Arms, Self-Designing Two-Stage Trials to Minimize Expected Costs, A Bayesian adaptive design for two-stage clinical trials with survival data, Inference of non-centrality parameter of a truncated non-central chi-squared distribution, Adaptive Multivariate Global Testing, Exact Confidence Bounds Following Adaptive Group Sequential Tests, Procedures for testing multiple endpoints in clinical trials: an overview, An Approach to the Conditional Error Rate Principle with Nuisance Parameters, Basic concepts of group sequential and adaptive group sequential test procedures, Optimal adaptive two-stage designs for phase II cancer clinical trials, Adaptive Design for Censored Survival Data Adjusting for Covariates, Are Flexible Designs Sound?, THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL, ESTIMATION FOLLOWING EXTENSION OF A STUDY ON THE BASIS OF CONDITIONAL POWER, Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications